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Abstract: West Nile virus (WNV) infection results in a spectrum of neurological symptoms, ranging
from a benign fever to severe WNV neuroinvasive disease with high mortality. Many who recover
from WNV neuroinvasive infection present with long-term deficits, including weakness, fatigue,
and cognitive problems. While neurons are a main target of WNV, other cell types, especially
astrocytes, play an important role in promoting WNV-mediated central nervous system (CNS)
damage. Conversely, it has been shown that cultured primary astrocytes secrete high levels of
interferons (IFNs) immediately after WNV exposure to protect neighboring astrocytes, as well as
neurons. However, how intrinsic responses to WNV in specific cell types and different regions of
the brain modify immune protection is not fully understood. Here, we used a mouse ex vivo spinal
cord slice culture (SCSC) and cerebellar slice culture (CSC) models to determine the innate immune
responses specific to the CNS during WNV infection. Slices were prepared from the spinal cord
and cerebellar tissue of 7–9-day-old mouse pups. Four-day-old SCSC or CSC were infected with
1 × 103 or 1 × 105 PFU of WNV, respectively. After 12 h exposure to WNV and 3 days post-infection
in normal growth media, the pooled slice cultures were processed for total RNA extraction and for
gene expression patterns using mouse Affymetrix arrays. The expression patterns of a number of
genes were significantly altered between the mock- and WNV-treated groups, both in the CSCs and
SCSCs. However, distinct differences were observed when CSC data were compared with SCSC.
CSCs showed robust induction of interferons (IFNs), IFN-stimulated genes (ISGs), and regulatory
factors. Some of the antiviral genes related to IFN were upregulated more than 25-fold in CSCs as
compared to mock or SCSC. Though SCSCs had twice the number of dysregulated genes, as compared
CSCs, they exhibited a much subdued IFN response. In addition, SCSCs showed astrogliosis and
upregulation of astrocytic marker genes. In sum, our results suggest that early anti-inflammatory
response to WNV infection in CSCs may be due to large population of distinct astrocytic cell types,
and lack of those specialized astrocytes in SCSC may make spinal cord cells more susceptible to WNV
damage. Further, the understanding of early intrinsic immune response events in WNV-infected ex
vivo culture models could help develop potential therapies against WNV.
Brain Sci. 2019, 9, 1; doi:10.3390/brainsci9010001 www.mdpi.com/journal/brainsci
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1. Introduction
West Nile virus (WNV) is a single-stranded RNA flavivirus that has a natural life cycle between
birds and mosquitoes [1,2]. The spectrum of WNV infection in humans can range from a flu-like
febrile illness to acute flaccid paralysis, meningitis, or encephalitis [3,4]. Neuroinvasive WNV infection
has a high mortality rate, and many who recover present with long-term symptoms for years [5].
The most debilitating is an acute asymmetric poliomyelitis-like weakness with or without signs of
viremia or meningoencephalitis [2,6]. Recent reports suggest a link between West Nile infection and
myasthenia gravis, as observed in patients with no prior history of myasthenia gravis that developed
this autoimmune disorder 3 to 7 months after recovery from neuroinvasive WNV disease [7,8].
A post-infectious pro-inflammatory state was hypothesized to contribute to the long-term lingering
symptoms and to promote autoimmune disorders.
Histopathologic examination of brain and spinal cord tissues from nine victims of WNV neuroinvasive
disease showed perivascular inflammation, microglial nodules, neuronophagia, and variable necrosis and
neuronal loss [9]. These changes were dominant in the deep nuclei of the brain and anterior horns of
the spinal cord. Focal demyelination, gliosis, and occasional perivascular infiltrates were also seen
among patients with prolonged clinical courses [10]. Leis et al. [11] examined the serum and CSF of
WNV patients who first had symptoms 2–18 days prior to sampling, and found elevated levels of glial
fibrillary acidic proteins (GFAP)-SM 126 and S100B, suggesting astroglial activation [11,12].
The precise pathogenesis of WNV neuroinvasive disease is not yet clear [13]. Some of the in vitro
studies showed capsid protein-induced apoptosis in the neurons through the activation of mitochondrial/
caspase-9 and caspase-3 pathway during WNV infection [14], whereas other studies have shown that
the infected neurons die due to the involvement and activation of immune cells such as cytotoxic T
cells, as these neurons express higher amounts of MHC class I molecules [15,16]. However, a slice
culture study of spinal cord showed that the CNS resident cells and microglia initiate a strong immune
response against WNV infection by secreting large number of chemokines and cytokines [17].
One of the earliest innate host responses to a viral infection is the induction of type 1 interferon
(IFN), especially IFN-α/β. This response is initiated by different types of cellular pathogen-recognizing
receptors (PRRs), which can sense viral invasion [18,19]. They include several of the toll-like
receptors (TLRs) and a number of cytosolic receptors detecting nucleic acid sequences indicative
of viral presence within the host cell [18,19]. Once the PRRs are activated by viral molecular
patterns, several transcription factors, including interferon regulatory factors (IRFs), activator protein
1 (AP-1), and NF-κB, are activated and translocated into the nucleus to induce the expression of
pro-inflammatory cytokines and type I IFNs [20,21]. These secreted IFNs bind to the locally expressed
IFN-α/β receptor in a paracrine and autocrine manner, and signal through the JAK-STAT pathway,
which induces the expression of many IFN-stimulated genes (ISGs) [20,21]. It has been shown that
fast type I IFN response protects astrocytes from flavivirus infection and virus-induced cytopathic
effects [22]. IFN-inducible GTPase superfamily is also a prominent group of enzymes that operate
against pathogens, and can bind and hydrolyze GTP [23]. These enzymes are involved in pathogen
recognition, macrophage motility, autophagy, and phagosome maturation [24]. The well-known
members of IFN-inducible GTPases that have been shown to participate in host defense include
guanylate-binding proteins (GBPs) and immunity-related GTPase family M protein [23,25].
Lindqvist et al. [22] showed that the type I IFN response in astrocytes efficiently restricts the
spread of both tick- and mosquito-borne neurotropic flaviviruses, including WNV, and prevents
virus-induced killing of the cells. Experiments using IFN alpha receptor deficient (IFNAR−/−)
astrocytes indicated that the IFN response was required for the restriction of mosquito-borne flavivirus
spread in astrocytes. Lindqvist et al. [22] also showed that astrocytes from IFNAR−/− mice were
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more susceptible to flavivirus infection as compared to wildtype astrocytes, and this could be due
to lowered basal expression of antiviral ISGs, such as viperin. Although, it has been suggested that
astrocytes protect neighboring cells via IFN induction, it remains unknown if this response is generic
or specific to different regions of the CNS. Thus, in this study, we used a mouse ex vivo spinal cord
slice culture (SCSC) and cerebellar slice culture (CSC) models to determine similarities and differences
in the innate immune responses during WNV infection of the two distinct CNS regions.
2. Methods
2.1. Cerebellar and Spinal Cord Slice Cultures
For CSC and SCSC, 7–9-day-old Brainbow/parvalbumin (PV) or GFP transgenic mouse pups
were used [26]. Homozygous GFP mice were obtained from Jackson Labs, Bar Harbor, Maine. We have
a colony of GFP transgenic mice in our animal facility [26]. The transgene expression is under the
control of Purkinje cell specific pcp2/L7 promoter. Therefore, GFP is expressed only in Purkinje cells,
where it fills dendrites, soma, axons, and nuclei. GFP fluorescence is detected in Purkinje cells as early
as E17, and increases during development. Homozygous GFP mice are not very different from the
wildtype animals with respect to growth, life span, and fertility. To obtain Brainbow-PV pups, we bred
homozygous PV-Cre knockin mice (Jackson labs) with homozygous Thy1-Brainbow (Jackson Labs) to
get distinguishable color variations in PV specific Cre recombined cells, especially in the cerebellum.
PV-driven Cre expression did not affect the normal expression of PV.
All animal protocols were approved by the Institutional Animal Care and Use Committee at the
University of Mississippi Medical Center. This research complies with the ‘3R’. Whole cerebellum
and spinal cord was dissected out. Meninges were carefully removed using a dissection microscope.
Tissue was rinsed and placed in Petri dishes containing 5% glucose and cold Gey’s balanced salt
solution (Sigma-Aldrich, St Louis, MO, USA). Cerebellar and spinal cord tissues were cut into 300 µm
slice sections using a McIlwain tissue chopper. Slices were suspended in cold Gey’s solution containing
5% glucose, then grown on Millicell membrane inserts (Fisher, Houston, TX, USA) using 6-well culture
plate containing 1 mL plating media (v/v: 5% 10× Basal Medium with Earle’s Salt, 2.5% 10×HBSS, 25%
horse serum (Invitrogen, Waltham, MA, USA), 1% 100× Pen–Strep–Glutamine, 4.5% of 10% D-glucose,
0.5% of 7.5% sodium bicarbonate, and 61.5% sterile water, Sigma, St. Louis, MO, USA). Tissue cultured
plates were incubated overnight at 35.5 ◦C with 5% CO2 and 100% humidity. Old growth media was
replaced by fresh media the following day followed by feeding twice a week. After confirming that
cultures were healthy and viable, they were transported to a biosafety level 3 facility at the University
of Southern Mississippi for WNV infection.
2.2. Infection with WNV
Five to seven days in vitro (DIV) old cerebellar slices were infected with 1× 103, 1× 105, or 1× 107
PFU, and the spinal cord slices with 1× 103 PFU of WNV. The infection protocol of Quick et al. [17] was
followed. After 12 h exposure to WNV and an additional 72-h incubation in the normal growth media,
the pooled slice cultures were processed for total RNA extraction. Total RNA collected from 3 samples
(pooled)/group were analyzed for the gene expression patterns using mouse Affymetrix arrays at the
Institute’s genomics and molecular core facility. Some slice cultures were fixed for immunofluorescence.
2.3. Immunofluorescence
Slice cultures were fixed in 4% PFA, exposed to GFP (Roche Applied Sciences, Madison, WI,
USA) or GFAP (Sigma-Aldrich, St. Louis, MO, USA) antibodies, and then incubated with fluorescent
secondary antibodies Alexa 488 or Alexa 546 (Invitrogen, Waltham, MA, USA). Some sections were
stained with DAPI (Invitrogen) to localize nuclei. Immunostained Purkinje cells in CSC and astrocytes
in SCSC were visualized under an Olympus BX60 epifluorescence microscope. Digitized images were
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quantified with ImageJ as previously described [26]. For statistical analysis, the Student’s unpaired
t-test was used and the p < 0.05 was considered statistically significant.
2.4. RNA Extraction and Gene Array Analysis
Total RNA was extracted from the pooled samples containing around 12 cerebellar or 18–24
spinal cord slices/sample with RNA-extraction kit (A260/A280 ratio of 1.95 or above) or with RNA
prep reagent (Trizol, ThermoFisher, Houston, TX, USA). Each RNA sample was amplified and
labeled according to the Affymetrix protocol and hybridized on the Mouse 430 2.0ST GeneChip
(UMMC’s Molecular and Genomics Facility). Array data were normalized, and signals were
transformed to a log scale. The microarray data analysis was performed using Affymetrix® Expression
Console™ (Affymetrix-Thermo Fisher, Houston, TX, USA) and GeneSifter™ Software (VizX Labs, LLC,
Seattle, WA, USA; http://www.genesifter.net). GeneSifter offers a robust statistical framework with
15 advanced options, including 2-way ANOVA, PCA, PAM, hierarchical clustering, etc. For statistical
analysis, the Student’s t-test with Bonferroni’s correction was used, and the p < 0.05 was considered
statistically significant. Genes that showed significant up- or downregulation (p < 0.05) with
fold-changes >+1 or <−1 were identified and selected using annotation information from Gene
Ontology and KEGG Pathway analysis.
3. Results
We used ex vivo CSC and SCSC models to determine the innate immune response specific to
the CNS during early stages of WNV infection. To infect cultures with WNV, the method of Quick
and co-workers [17] was followed. Since cerebellum has a higher density of cells than spinal cord,
we used 105 PFU WNV/4 cerebellar slices/insert, and 103 PFU WNV/6–8 spinal cord slices/insert.
The inoculum was washed off at 12 h for all samples. We observed that astrocytes in mock-infected
SCSCs were distributed throughout the sliced tissue and had the characteristic cellular shape (Figure 1),
whereas WNV-infected samples contained reactive astrocytes, with notably enlarged cell bodies and
more processes. Morphologic changes in CSCs occurred at higher doses (107 PFU) of WNV, as shown
in Figure 2, where Purkinje cells in WNV-exposed slices show shrunken or pruned dendritic arbors
and reduced GFP immunostaining as compared to mock. The total GFP immunoreactive area of these
images was quantified with ImageJ. The total area of WNV-treated Purkinje cells was significantly lesser
(3736 ± 525.2, n = 5) than mock-treated Purkinje cells (9330 ± 1226, n = 3). The data is presented as
mean± SEM and p < 0.003. For statistical analysis, the Student’s unpaired t-test was used, and p < 0.05
was considered statistically significant.
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FP localization, especially in the dendritic spines of Purkinje cells, is heterogeneous [26], the slices
ere immunostained with GFP antibody to enhance visualization. Purkinje cells (PCs) in WNV-exposed
cultures show shrunken or pruned dendritic arbors and reduced GFP immunostaining as compared
to ock cultures. The total GFP immunoreactive area of these images was quantified with ImageJ.
The total area of WNV-treated PCs was significantly less (3736 ± 525.2, n = 5) than mock-treated PCs
(9330 ± 1226, n = 3). The data are presented as mean ± SEM and p < 0.003.
At 3 days post-infection (dpi), Quick et al. [17] showed that WNV antigen was present in 27%
of neurons and less than 11% astrocytes, and about 6% of the microglia contained WNV at 3 dpi.
They further observed that by 7 dpi, the majority of neurons and a substantial percentage of astrocytes
in SCSCs were infected with WNV, resulting in apoptotic cell death and astrogliosis.
Gene expression profiling studies with mock- and WNV-treated SCSC or CSC were carried out
to identify novel gene signatures related to CNS intrinsic immune response genes that modulate
WNV infection. Comparison of the differently expressed genes from WNV-treated CSC revealed both
common and unique transcripts across 103, 105, and 107 PFU treatment doses of WNV (Figure 3).
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control of flavivirus infection in mammalian cells.
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Figure 4. Hierarchical gene clusters (red circles) of expressed genes after treatment with different doses
of WNV in cerebellar slice cultures. The left-most column represents mock treatment.
In the early phase of infection, viral nucleic acid sensing induces nuclear localization of IRFs,
which stimulate gene transcription and production of IFN-α/β by infected cells. In the later phase,
these IFNs bind to the common IFN-α/β receptor in a paracrine and autocrine manner and signal
through the JAK-STAT pathway, resulting in the induced expression of hundreds of ISGs. Viperin is
one of the ISGs with antiviral activity against WNV [20,21]. Some of the highly upregulated ISGs in
post-WNV-infected CSC are listed in Table 1. The upregulation was dose dependent.
Table 1. Dose-dependent upregulation of the selected interferon (IFN)-induced and associated genes
in mouse CSCs infected with WNV. CSCs were treated with 103, 105, or 107 PFU of WNV.
Gene Name Gene Designation 103 PFU Fold Upregulation 105 PFU 107 PFU
Interferon-induced protein 44 Ifi44 127 162 156
Lymphocyte antigen 6 complex locus A Ly6a 80 114 136
Interferon-induced protein with
tetratricopeptide repeats Ifit1 29 37 40
Viperin Rsad2 24 29 33
Further, for statistical analysis with sample size of three (n = 3) per group, total RNA was collected
by pooling 9 CSCs or 18–24 SCSCs (WNV treated or mock) per sample, and were subjected to gene
expression pr filing using mouse Affymetrix arrays. The Stud nt’s t-test with Bonferroni’s correction
(p < 0.05) revealed that, in SCSCs, 6884 genes were upregulated and 2756 were downregulated.
By contrast, only 2756 ge es were upregulated and 3856 downregulated in the CSCs (Tables 2–4).
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Table 2. WNV-induced gene regulation in mouse CSCs and SCSCs. Number of genes up- or
downregulated. Total number of dysregulated genes.
Gene Category Cerebellum (Total) Spinal Cord (Total)
Upregulated 2756 6884
Downregulated 3856 5853
Microarray analysis was performed on RNA extracted from the mouse cerebellar and spinal cord slices infected
with WNV. The data (n = 3 per group) were analyzed using Student’s t-test with Bonferroni’s correction. p < 0.05
was considered statistically significant.
Table 3. Genes associated with IFN signaling are highly upregulated in the mouse CSCs infected with
WNV. The data (n = 3) were analyzed using Student’s t-test with Bonferroni’s correction (p < 0.05
statistically significant).
Function Gene Designation Name Fold Upregulation p Value
Chemoattractant
for immune cells Cxcl10 C–X–C motif chemokine 10 22.86 0.0045
Ccl5 Chemokine (C–C motif) ligand 5 27.82 5.47 × 10−5
IFN-inducible
GTPase Irgm1
Immunity-related GTPase family M
member1 12.82 1.08 × 10
−6
Irgm2 Immunity-related GTPase family Mmember2 21.35 2.03 × 10
−6
Gbp2 Guanylate-binding protein-2 26.40 3.73 × 10−6
Gbp6 Guanylate-binding protein-6 20.26 1.19 × 10−6
Regulation of IFN
signaling Usp18 Ubiquitin-specific peptidase 18 43.58 3.94 × 10
−6
Nlrc5 NLR family, CARD domaincontaining 5
Ifna2 Alpha interferon 2 1.92 0.0235
Acute-phase
response Saa3 Serum amyloid A 3 3.88 0.0071
IFN-induced
antiviral activity Rsad2
Viperin (radical S-adenosyl
methionine domain-containing 2) 28.11 3.09 × 10
−7
Ifit1 IFN-induced protein withtetratricopeptide repeats1 47.51 8.25 × 10
−8
Ifit2 IFN-induced protein withtetratricopeptide repeats2 9.08 4.07 × 10
−6
Osal2 2′–5′ oligoadenylate synthase-like 2 52.36 1.09 × 10−5
IFN-induced,
unknown function Slfn4 Schafen 4 2.67 0.00047
Ifi44 Interferon-induced protein 44 96.71 7.67 × 10−7
IFN-induced
apoptosis Lcn2 Lipocalin2 [27] 3.65 0.00026
Table 4. Genes associated with IFN signaling are altered in the mouse spinal cord slice cultures infected
with WNV.
Function Gene Designation Name Fold-Change p Value
Chemoattractant for immune cells Cxcl10 C–X–C motifchemokine 10 1.52↑ 0.0344
IFN-inducible GTPase Gbp6 Guanylate-bindingprotein-6 1.91↓ 0.0112
IFN-induced apoptosis Lcn2 Lipocalin2 1.66↑ 0.0347
The expression patterns of a number of genes were significantly altered between the mock- and
WNV-treated groups both in the CSCs and SCSCs (Figures 3 and 4). However, there were distinct
differences, such that CSCs showed robust induction of interferons (IFNs), IFN-stimulated genes (ISGs),
and interferon regulatory factors (IRFs), which was not seen in SCSCs. Gene sets related to many other
cellular processes were also affected. Additionally, numerous genes specific to non-protein-coding
mRNAs were found (GEO accession number GSE123793). However, in this manuscript, we are only
reporting alterations in the interferon-related genes and chemokines and/or cytokines.
We used volcano plots to assess the magnitude of fold-change of gene expression to statistical
significance [28,29], which allowed us to find genes of interest and then compares and contrasts the data
of CSC with SCSC (Figure 5). The volcano plot arranges genes along two dimensions. The horizontal
Brain Sci. 2019, 9, 1 8 of 13
dimension is the fold-change between the two groups on a log scale, and the vertical dimension
represents the p-value for a t-test of differences between samples represented by a negative log scale
(−log10 of p value), thus smaller p-values are placed higher up. The magenta line shows p = 0.05
cut-off with points above the line falling in the p < 0.05 region and points below the line in the p > 0.05
region (Figure 5). The red points indicate upregulated genes and green downregulated genes. Gray
indicates points with a fold-change less than 2 (log2 = 1).
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Clarke et al. [27] showed that the intracerebral infection of the mouse brain with WNV led to the
differential regulation of many genes within the CNS. They used Ingenuity Pathway Analysis and
reported 23 IFN signaling genes with the highest levels of upregulation (50-fold), which included genes
expressing GTPases, antiviral proteins, immune cell attractants, and proteins involved in the regulation
of IFN signaling. We compared our data with Clarke et al. [27] and presented it in Tables 3 and 4.
CSCs showed robust induction of interferons (IFNs), IFN-stimulated genes (ISGs), and regulatory
factors (Table 3). Some of the antiviral genes related to IFN were upregulated more than 25-fold
in CSCs as compared to mock. By contrast, though SCSCs had twice the number of dysregulated
genes as compared to CSCs, they exhibited much subdued induction of ISGs (Table 4). Clarke and
co-workers [27] also used brain slice culture to examine WNV-induced pathogenesis in the absence of a
peripheral immune response and suggested that WNV-induced neuronal injury in the brain is mediated
by death receptor-induced apoptosis. IFN-induced apoptosis gene lipocalin2 (Lcn2) was upregulated
56-fold. In our CSC and SCSC, Lcn2 was upregulated <4-fold and <2-fold, respectively, indicating that
apoptosis may not be the primary pathway influencing WNV pathogenesis in our models.
Lindqvist et al. [22] reported that astrocytes respond very quickly after viral infection by
upregulation of type I IFNs. This upregulation restricts virus replication and spread in primary
cultures, and contributes to cell survival. We looked at some of the upstream activator genes proposed
by Lindqvist et al. [22] that were significantly upregulated in their astrocytic primary cultures (Figure 6).
Interestingly, many similar IFN-α/β upstream activator genes were upregulated by several fold in
CSC (Figure 6). By contrast, except FGL2 (1.5-fold) and CCRL2 (1.1-fold), none of the other genes
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listed in Figure 6 were significantly different as compared to mock in SCSC, which suggests that the
cerebellar microenvironment may have stronger innate antiviral defenses than spinal cord. Our recent
data (unpublished) is supportive of this argument. Mice chronically exposed to a single sublethal dose
of WNV showed spinal cord susceptibility and a much higher number of dysregulated genes than
cerebellum. We believe that most of the ISGs or regulatory factors upregulated in WNV-infected CSC
are specifically associated with the astrocytic population of those slice cultures.
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4. Discussion
We used two ex vivo slice culture models to compare and contrast the early intrinsic CNS immune
respons of resident cells in different CNS region during WNV i fe tion. The rationale fo u ing ex
v vo models was that slice cultur s are able to maintain the cytoarchitecture of the CNS, which allows a
thorough understanding of the functions of multiple int rc nnected cells in a culture system that closely
resembles the in vivo enviro ment [17]. Additionally, whereas experimental mouse models of WNV
infection were abl to show the importance of innate and adaptive immune respons s in controlli g
the ext nt and everity of CNS diseas , they could not clearly differentiate immune responses intrinsic
to the CNS from those tha are dependent on infiltrating inflamma or cells [17,30–32].
To understand the early intrinsic anti-inflammatory response i the CNS, we looked at the effects
of WNV infection as early as 3 dpi. Quick and co-workers [17] also reported that at 3 dpi, only 27% of
neurons, less than 11% astrocytes, and about 6% microglia were infected with W V. In anoth r study,
Clarke et al. [27] i vestigated WNV-in uced injury to brain slice cultures by de rmining the levels
of lactate dehydrog nase (LDH) in the media of WNV-infected ultures compar d to mock-infected
co trols. No LDH le k was detected at 3 dp , suggesting negligible to the brain slice cult res at
3 dpi [27]. Further, at 3, 5, 7, and 9 dpi, caspase 3 ctivity assays were used to determine the amo nt of
WNV-induced apoptosis in brai slice cultures. At 3 dpi, th fold increase in caspase 3 activ ty infected
vs. mock was not significant. We also did not see any upregulation of caspase 3 gene expression either
in CSC or SCSC. At 3 dpi, mild astrogliosis was seen in our SCSCs (Figure 1) and Purkinje cell damage
was visible only in 107 PFU WNV-treated CSCs (Figure 2).
Adult mice infected with 100 PFU WNV by intracerebral inoculation [27] showed 50-fold
upregulation of about 23 genes involved in IFN signaling, including genes expressing GTPases,
antiviral proteins, immune cell attractants, and proteins involved in the regulation of IFN signaling.
Several antiviral ISGs, including viperin, have been identified as inhibitors of WNV, and are also
downregulated in IFNAR−/− astrocytes, and upregulated after treatment with IFNαB/D and
supernatant [22], and could, thus, contribute to antiviral response against WNV in astrocytes [33–35].
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In addition, Lindqvist et al. [22] were able to predict upstream regulators responsible for the differential
expression patterns in IFNAR−/−-, supernatant-, and IFNαB/D-treated astrocytes, and identified
type I IFN, as well as IFN signaling molecules, to have the highest activation scores. IFNγ-STAT1-IRF-1
signaling cascade was predicted as an upstream regulator both in supernatant and IFNαB/D-treated
astrocytes [22]. Similar observations were made in our study, where IFN signaling and antiviral
mediators were among the most upregulated genes in WNV-infected CSCs (Tables 1 and 3; Figure 6).
Mammalian cells have been shown to detect WNV and induce type 1 IFNs during the earliest
stages of WNV infection after host cell recognition of viral RNA, and mice with genetic defects in
the receptor for IFN-α/β, or constituents of its signaling cascade, show markedly enhanced viral
accumulation in tissues, leading to rapid lethality [36]. WNV has evolved to counter IFN function of
restricting viral infection and to limit its efficacy. It also attenuates IFN function at multiple steps of
the induction and signaling cascade [37–42]. Indeed, WNV is resistant to the antiviral effects of IFN in
cell culture once infection is established, which may explain the relatively narrow therapeutic window
for IFN administration that has been observed in animal models or humans infected with WNV [43].
Viperin plays an important player in mediating the IFN-dependent antiviral response and
inhibiting a number of viruses at various stages of their life cycles [44–46]. A few studies have
sought to define the function of viperin in vivo. For WNV, higher viral burdens were observed
in the spleen, kidney, and brain in the absence of viperin, which suggests greater susceptibility of
viperin−/− mice to infection [33]. Astrocytes are important producers of IFNs during neurotropic
viral infections [47,48]. Lindqvist et al. [22] have shown that IFN signaling controls flavivirus infection
and that viperin is highly upregulated in astrocytes. They further demonstrated that WNV infection
was significantly reduced after 48 hpi in viperin−/− cortical neurons treated with IFN, indicating that
other ISGs also contribute to the IFN-mediated antiviral responses against WNV [46]. Furthermore, the
antiviral effects of viperin are restricted to the specific brain regions [46]. Our data also show 28-fold
and dose-dependent upregulation of viperin in CSCs (Tables 1 and 3; Figure 6), however, no change
in viperin gene expression was seen in SCSC. We speculate that viperin mediates CNS region- and
cell-type-specific inhibition of WNV. Our results suggest that early anti-inflammatory response to
WNV infection in CSCs may possibly be due to a large population of specialized Bergmann astroglial
cells in the cerebellum. We further speculate that lack of such specialized astrocytes in SCSC may make
spinal cord more susceptible to WNV damage. Indeed, this finding may help to explain the clinical
susceptibility of grey matter of human spinal cord to WNV infection. The most common neuromuscular
manifestation of WNV infection is an acute flaccid paralysis attributed to a poliomyelitis syndrome
with asymmetric paralysis variably involving one (monoparesis) to four limbs (quadriparesis), with or
without brainstem involvement and respiratory failure [9,49]. This syndrome of acute flaccid paralysis
may occur without overt fever or meningoencephalitis. Involvement of anterior horn cells in the spinal
cord is the major site of pathology responsible for the neuromuscular deficits.
In sum, our results suggest that early anti-inflammatory response to WNV infection in CSCs may
be due to large population of distinct astrocytic cell types, and lack of those specialized astrocytes in
SCSC may make spinal cord cells more susceptible to WNV damage.
5. Conclusions
The use of ex vivo slice cultures of cerebellum and spinal cord tissue has enabled us to determine
similarities and differences between the innate immune responses of the resident CNS cells from
different regions, especially the response of astrocytes to WNV infection. Since no effective treatment
strategy is currently available for managing WNV neuroinvasive disease, the understanding of early
neuroprotective or pathologic events in WNV-infected ex vivo culture models could help develop
potential therapeutics.
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